AMAM Annual Revenue
$7.40 M
-$53.00 K-0.71%
31 December 2022
Summary:
As of January 27, 2025, AMAM annual revenue is $7.40 million, with the most recent change of -$53.00 thousand (-0.71%) on December 31, 2022. During the last 3 years, it has fallen by -$2.91 million (-28.21%).AMAM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMAM Quarterly Revenue
$53.00 K
-$1.07 M-95.28%
01 September 2023
Summary:
As of January 27, 2025, AMAM quarterly revenue is $53.00 thousand, with the most recent change of -$1.07 million (-95.28%) on September 1, 2023. Over the past year, it has dropped by -$1.54 million (-96.68%).AMAM Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMAM TTM Revenue
$4.09 M
-$1.54 M-27.39%
01 September 2023
Summary:
As of January 27, 2025, AMAM TTM revenue is $4.09 million, with the most recent change of -$1.54 million (-27.39%) on September 1, 2023. Over the past year, it has dropped by -$416.00 thousand (-9.23%).AMAM TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMAM Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.7% | -96.7% | -9.2% |
| 3 y3 years | -28.2% | - | - |
| 5 y5 years | -28.2% | - | - |
AMAM Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -45.9% | -98.2% | -44.7% |
Ambrx Biopharma Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $53.00 K(-95.3%) | $4.09 M(-27.4%) |
| June 2023 | - | $1.12 M(+4579.2%) | $5.64 M(-3.0%) |
| Mar 2023 | - | $24.00 K(-99.2%) | $5.81 M(-21.5%) |
| Dec 2022 | $7.40 M | $2.89 M(+81.2%) | $7.40 M(+64.2%) |
| Sept 2022 | - | $1.60 M(+22.9%) | $4.51 M(+54.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $1.30 M(-19.5%) | $2.91 M(+80.5%) |
| Mar 2022 | - | $1.61 M | $1.61 M |
| Dec 2021 | $7.46 M(-45.5%) | - | - |
| Dec 2020 | $13.67 M(+32.6%) | - | - |
| Dec 2019 | $10.31 M | - | - |
FAQ
- What is Ambrx Biopharma annual revenue?
- What is the all time high annual revenue for Ambrx Biopharma?
- What is Ambrx Biopharma annual revenue year-on-year change?
- What is Ambrx Biopharma quarterly revenue?
- What is the all time high quarterly revenue for Ambrx Biopharma?
- What is Ambrx Biopharma quarterly revenue year-on-year change?
- What is Ambrx Biopharma TTM revenue?
- What is the all time high TTM revenue for Ambrx Biopharma?
- What is Ambrx Biopharma TTM revenue year-on-year change?
What is Ambrx Biopharma annual revenue?
The current annual revenue of AMAM is $7.40 M
What is the all time high annual revenue for Ambrx Biopharma?
Ambrx Biopharma all-time high annual revenue is $13.67 M
What is Ambrx Biopharma annual revenue year-on-year change?
Over the past year, AMAM annual revenue has changed by -$53.00 K (-0.71%)
What is Ambrx Biopharma quarterly revenue?
The current quarterly revenue of AMAM is $53.00 K
What is the all time high quarterly revenue for Ambrx Biopharma?
Ambrx Biopharma all-time high quarterly revenue is $2.89 M
What is Ambrx Biopharma quarterly revenue year-on-year change?
Over the past year, AMAM quarterly revenue has changed by -$1.54 M (-96.68%)
What is Ambrx Biopharma TTM revenue?
The current TTM revenue of AMAM is $4.09 M
What is the all time high TTM revenue for Ambrx Biopharma?
Ambrx Biopharma all-time high TTM revenue is $7.40 M
What is Ambrx Biopharma TTM revenue year-on-year change?
Over the past year, AMAM TTM revenue has changed by -$416.00 K (-9.23%)